Thomas M. Ellis - Concepedia

Author

Thomas M. Ellis

Also Known As

T Ellis, T M Ellis, T. Ellis, T. M. ELLIS, T. M. Ellis, T.M. Ellis, THOMAS M. ELLIS, Thomas Ellis, Thomas M Ellis, Thomas M. Ellis

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Loyola University Chicago Versiti Blood Center of Wisconsin University of Wisconsin–Madison Medical College of Wisconsin Virginia Commonwealth University Medical Center

About

Thomas M. Ellis is an author at Loyola University Chicago specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	23	1.2K
2	Allergy	3	3	128
3	Natural Sciences	2	2	84
4	Health Sciences	1	1	55
5	Biochemistry	1	1	12

Thomas M. Ellis

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer Maria Mercader, Barbara Bodner, Micheal T. Moser, Proceedings of the National Academy of Sciences	2001	383
CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells. Thomas M. Ellis, Patricia Simms, D J Slivnick, The Journal of Immunology Radiation OncologySignal TransductionMedicineCd45ro+ T CellsT-regulatory Cell	1993	204
C1q Binding Activity of De Novo Donor-specific HLA Antibodies in Renal Transplant Recipients With and Without Antibody-mediated Rejection Maggie Yell, Brenda Muth, Dixon B. Kaufman, Transplantation	2015	124
CD30 defines a subset of activated human T cells that produce IFN-<i>gamma</i> and IL-5 and exhibit enhanced B cell helper activity. Mortimer T. Alzona, Hans‐Martin Jäck, Richard I. Fisher, The Journal of Immunology	1994	118
Alterations in peripheral B cells and B cell progenitors following androgen ablation in mice Thomas M. Ellis, Michael T. Moser, Phong T. Le, International Immunology Lymphocyte DevelopmentImmunologyFemale Reproductive FunctionB Cell ProgenitorsHematology	2001	99
Current outcomes of chronic active antibody mediated rejection – A large single center retrospective review using the updated BANFF 2013 criteria Robert R. Redfield, Thomas M. Ellis, Weixiong Zhong, Human Immunology Transplant RejectionTransplantationAutoimmune DiseaseChronic Active AntibodyImmunosuppressive Therapy	2016	86
The impact of Hodgkin's disease on the immune system. D J Slivnick, Thomas M. Ellis, John F. Nawrocki, PubMed	1990	84
The virtual crossmatch – A screening tool for sensitized pediatric heart transplant recipients Steven Zangwill, Thomas M. Ellis, Jane Zlotocha, Pediatric Transplantation	2005	80
In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2. J. McMannis, Richard I. Fisher, Stephen P. Creekmore, The Journal of Immunology Lak CellsImmunologyNk CellsImmunologic MechanismCancer Patients	1988	79
Antithymocyte Globulin Is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients Marissa M. Brokhof, Hans W. Sollinger, David Hager, Transplantation	2014	73

Page 1